• PD0325901: MEK Inhibitor Workflows for Cancer and Stem Cell

  2026-04-19

  PD0325901 empowers precise MEK pathway inhibition in cancer and stem cell models, enabling robust analysis of cell fate, apoptosis, and tumor suppression. This guide delivers actionable protocols, troubleshooting tips, and workflow enhancements for maximizing PD0325901’s impact in experimental settings.

• Dual-Fluorescence Cy5-labeled mRNA: Transforming Quantitativ

  2026-04-18

  Explore how EZ Cap™ Cy5 EGFP mRNA (5-moUTP) revolutionizes quantitative mRNA delivery and translation efficiency assays with dual-fluorescence and Cap 1 innovation. Distinct from prior reviews, this article bridges practical assay design with state-of-the-art nanoparticle insights.

• Palonosetron in CINV: Clinical Advances and Translational Re

  2026-04-17

  This article reviews Ruhlmann & Herrstedt's comprehensive evaluation of palonosetron hydrochloride for preventing chemotherapy-induced nausea and vomiting (CINV). The paper provides mechanistic insights, comparative efficacy data, and clinical guidance relevant to researchers studying chemotherapeutic regimens, including those featuring agents such as Irinotecan.

• ATS-9R: Precision Gene Silencing in Adipocytes for Obesity R

  2026-04-16

  ATS-9R (Adipocyte-targeting sequence-9-arginine) enables highly specific, efficient non-viral gene delivery to white adipose tissue, transforming workflows in obesity and diabetes research. Backed by translational evidence and robust performance data, this APExBIO solution streamlines gene silencing for metabolic disease modeling with unrivaled tissue selectivity.

• Protease and Phosphatase Inhibitor Cocktail: Precision in Pr

  2026-04-15

  Unlock unparalleled protein integrity in your research with the Protease and Phosphatase Inhibitor Cocktail (EDTA Free, 100X in ddH2O). This advanced, EDTA-free formulation from APExBIO empowers reliable preservation of phosphorylation and post-translational modifications during extraction, supporting workflows from cell signaling to proteomics.

• PF-04971729 (Ertugliflozin): Protocols and Troubleshooting f

  2026-04-14

  PF-04971729 (Ertugliflozin) sets a new benchmark for dissecting SGLT2-mediated glucose transport in diabetes mellitus research. This guide delivers actionable workflow enhancements, troubleshooting insights, and comparative advantages to ensure robust, reproducible experimentation.

• Starvation-Driven Autophagy–Apoptosis Switch in Bombyx via E

  2026-04-13

  This study elucidates how starvation triggers a regulated shift from autophagy to apoptosis in the Bombyx mori fat body, mediated by ER-derived Ca2+ signals and calpain protease activation. The work provides mechanistic insight into programmed cell death regulation under nutritional stress and highlights the use of 2-APB to dissect ER-Ca2+-dependent signaling in this context.

• Bifendate (DDB) as a CYP3A4 Modulator: Mechanistic Insights

  2026-04-12

  Explore how Bifendate (DDB) uniquely modulates CYP3A4 and autophagy pathways, advancing hepatoprotection strategies. This article delves into the mechanistic and translational science behind DDB, offering novel guidance for researchers and clinicians.

• Differential Volatile Mechanisms of Chuanxiong in CHD: Insig

  2026-04-12

  This study provides a high-resolution chemical and pharmacological comparison of cortex and pith from Ligusticum chuanxiong in coronary heart disease (CHD) prevention, revealing distinct active volatile compounds and molecular targets via advanced SPME-GC×GC-MS and network pharmacology. The findings clarify the tissue-specific contributions of LCH components, such as fenipentol, to cardiovascular modulation and highlight implications for targeted herbal and molecular studies.

• DiD (DiDC 18 (5)) for High-Fidelity Cell Membrane Staining

  2026-04-11

  APExBIO’s DiD (DiDC 18 (5)) Plasma Membrane Red Fluorescent Probe empowers researchers with uniform, high-sensitivity membrane labeling even in complex, autofluorescent tissues. Its proven compatibility with cell tracking, neuronal tracing, and immunofluorescence unlocks advanced workflows for dissecting inflammation, cell migration, and tissue remodeling.

• Biotin (Vitamin B7) in Protein Biotinylation & Metabolic Ass

  2026-04-11

  Biotin (Vitamin B7) stands at the interface of metabolic research and precision molecular labeling, enabling robust workflows for protein biotinylation and enzymatic assays. This article details best practices, protocol parameters, and troubleshooting strategies to maximize reproducibility and specificity in advanced biochemical experiments.

• Bifendate (DDB): Synthetic Schisandrin C Derivative for H...

  2026-04-10

  Bifendate (DDB) is a synthetic derivative of Schisandrin C and serves as a potent hepatoprotective agent. Clinically and preclinically, it demonstrates robust regulation of lipid metabolism and targeted autophagy inhibition, making it a leading compound for liver disease research and therapy.

• Bifendate (DDB) in Hepatoprotection: Scenario-Driven Solu...

  2026-04-09

  This article addresses laboratory challenges in hepatoprotection and lipid metabolism research, focusing on the robust, validated use of Bifendate (DDB, SKU BA1823) for cell-based and in vivo assays. Integrating real-world scenarios, it demonstrates how APExBIO’s Bifendate enables reproducible autophagy inhibition, lipid accumulation studies, and confident vendor selection, ensuring data reliability for biomedical researchers.

• Scenario-Driven Solutions for Cell Assays Using Bifendate...

  2026-04-08

  Discover how Bifendate (DDB) (SKU BA1823), a synthetic derivative of Schisandrin C, addresses key challenges in cell viability, proliferation, and cytotoxicity assays. This evidence-based guide explores real-world lab scenarios, optimized protocols, and interpretive strategies to enhance reproducibility and mechanistic insight in hepatic and non-hepatic research models.

• Bifendate (DDB): Synthetic Schisandrin C for Hepatoprotec...

  2026-04-08

  Bifendate (DDB), a synthetic derivative of Schisandrin C, acts as a potent hepatoprotective agent and regulator of lipid metabolism. Its unique mechanism includes autophagy inhibition, CYP3A4 modulation, and clinically validated efficacy in chronic hepatitis therapy.

450 records 21/30 page Previous Next First page 上5页 2122232425 下5页 Last page